Solid Biosciences (SLDB) Share-based Compensation Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.18% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.66% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 23.70% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 54.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.21% |
| Dec 31, 2025 | 70.11% |
| Sep 30, 2025 | 31.15% |
| Jun 30, 2025 | 50.33% |
| Mar 31, 2025 | 107.39% |
| Dec 31, 2024 | 97.16% |
| Sep 30, 2024 | 84.31% |
| Jun 30, 2024 | 7.61% |
| Mar 31, 2024 | -23.94% |
| Dec 31, 2023 | 22.12% |
| Sep 30, 2023 | 6.63% |
| Jun 30, 2023 | 7.17% |
| Mar 31, 2023 | -18.91% |
| Dec 31, 2022 | -53.53% |
| Sep 30, 2022 | -55.39% |
| Jun 30, 2022 | -50.10% |
| Mar 31, 2022 | -10.15% |
| Dec 31, 2021 | 35.62% |
| Sep 30, 2021 | 23.59% |
| Jun 30, 2021 | 12.09% |
| Mar 31, 2021 | -6.35% |
| Dec 31, 2020 | -26.03% |
| Sep 30, 2020 | -18.51% |
| Jun 30, 2020 | -17.08% |
| Mar 31, 2020 | -11.31% |
| Dec 31, 2019 | 67.68% |
| Sep 30, 2019 | 88.76% |
| Jun 30, 2019 | 198.78% |
| Mar 31, 2019 | 327.35% |
| Dec 31, 2018 | 146.66% |
| Sep 30, 2018 | 127.47% |
| Jun 30, 2018 | 168.79% |
| Mar 31, 2018 | -74.64% |